University of Miami/Sylvester Cancer Institute - Aventura, Aventura
University of Miami/Sylvester Cancer Institute - Lennar, Coral Gables
University of Miami/Sylvester Cancer Institute - Deerfield Beach, Deerfield Beach
외 8개

피험자 모집 중2상

12세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT02693535

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

SSAK Partners, Coral Springs
Mayo Clinic - Jacksonville, Jacksonville

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT07648264

ERd Combination Treatment in Newly Diagnosed Multiple Myeloma (ADVANCE 2.0)

University of Miami, Miami

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT06997081

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Baptist MD Anderson Cancer Center, Jacksonville
University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06615479

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

Mayo Clinic in Florida, Jacksonville
Miami Cancer Institute at Baptist Health, Inc., Miami
Moffitt Cancer Center, Tampa

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06297226

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

Mayo Clinic Florida, Jacksonville

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT06375044

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Moffitt Cancer Center, Tampa

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07075185

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

Research Site, Tampa

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT07681596

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

GSK Investigational Site, Fort Myers

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT07227311

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center, Coral Gables
University of Miami Hospital and Clinics - Deerfield Beach, Deerfield Beach
Sylvester Comprehensive Cancer Center- Doral, Doral
외 12개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT06152575

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

Sylvester Comprehensive Cancer Center - Aventura, Aventura
Sylvester Comprehensive Cancer Center- The Lennar Foundation Medical Center, Coral Gables
Sylvester Comprehensive Cancer Center - Coral Springs, Coral Springs
외 6개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT05020236

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

GSK Investigational Site, Pembroke Pines

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT05714839

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Holy Cross Hospital, Fort Lauderdale

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT04566328

IMMUNOPLANT for Newly Diagnosed Multiple Myeloma

University of Miami, Miami

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT06376526

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

Mayo Clinic Hospital - Florida, Jacksonville
University of Miami Don Soffer Clinical Research Center, Miami

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT05651932

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

Research Site, Jacksonville
Research Site, Miami
Research Site, Tampa

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT05850234

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

Research Site, Coral Gables
Research Site, Tampa

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 8. 14. 업데이트됨 · NCT07764978

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

University of Florida, Gainesville
University of Miami, Miami

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 8. 12. 업데이트됨 · NCT07280013

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Mayo Clinic in Florida, Jacksonville

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 8. 12. 업데이트됨 · NCT06630104

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Mayo Clinic - Florida, Jacksonville

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT07284758

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Mayo Clinic in Florida, Jacksonville

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT07285044

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

Moffitt Cancer Center /ID# 272628, Tampa

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 7. 21. 업데이트됨 · NCT06892522

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

Mayo Clinic in Florida, Jacksonville

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 7. 16. 업데이트됨 · NCT06121843

Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma

Mayo Clinic in Florida, Jacksonville

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 7. 14. 업데이트됨 · NCT05847569

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center, Coral Gables
University of Miami Hospital and Clinics Deerfield Beach, Deerfield Beach
Sylvester Comprehensive Cancer Center, Miami
외 2개

피험자 모집 중4상

18세 이상 · 모든 성별 · 2026. 7. 1. 업데이트됨 · NCT06057402

Integrated Cancer Repository for Cancer Research

Florida Hospital Memorial Medical Center, Daytona Beach
Florida Hospital DeLand, DeLand
Florida Hospital FISH, Orange City
외 2개

피험자 모집 중관찰 연구건강한 지원자 환영

19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Holy Cross Hospital, Fort Lauderdale
Mayo Clinic in Florida, Jacksonville
Jupiter Medical Center, Jupiter

피험자 모집 중3상

전 연령 · 모든 성별 · 2026. 6. 10. 업데이트됨 · NCT05561387

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

AdventHealth/Blood & Marrow Transplant Center, Florida Hospital Medical Group, Orlando
Moffitt at Memorial Healthcare System, Tampa

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT05243797

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.